Status:
COMPLETED
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Lead Sponsor:
Allergan
Conditions:
Ocular Hypertension
Eligibility:
All Genders
21+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess the safety and efficacy of Brimonidine/Timolol Fixed Combination in patients with glaucoma or ocular hypertension
Eligibility Criteria
Inclusion
- Clinical diagnosis of glaucoma or ocular hypertension in both eyes
- Patient requires IOP-lowering in both eyes
Exclusion
- Uncontrolled medical conditions
- Contraindication to beta-andrenoceptor antagonist or brimonidine therapy
Key Trial Info
Start Date :
July 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 1999
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT00332345
Start Date
July 1 1999
End Date
August 1 1999
Last Update
May 30 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Artesia, California, United States